Nonfused (i.e., nonhybrid) filamentous hemagglutinin (FHA) of BordeteUla pertussis was efficiently expressed in Escherichia coli K-12 and Salmonella typhimurium aroA at levels higher than those found in wild-type B. pertussis when the upstream signals of the gene were replaced and the translation initiation region was engineered to optimize translational efficiency. Inclusion of part of the C-terminal FHA open reading frame, whose translation product does not appear to be part of the major secreted species of FHA, was shown to be important in achieving protein expression in both E. coli and S. typhimurium aroA; removal of the downstream gene sequence abolished recombinant FHA production. The levels of expression observed varied widely according to the construct and host bacterium used.
Bordetella pertussis is the etiological agent of whooping cough, a major childhood respiratory disease that can develop serious complications and cause death (46) . Although whole-cell vaccine preparations routinely administered in combination with diphtheria and tetanus toxoids provide good protection against severe disease, increasing concern regarding the side effects of the vaccines has led to decreased vaccine acceptability, a decrease in the number of vaccinated infants, and a consequent increase in the incidence of whooping cough (24) .
B. pertussis produces a number of virulence factors, including pertussis toxin, adenylate cyclase, filamentous hemagglutinin (FHA), fimbriae, and major outer membrane proteins, whose synthesis is positively regulated by the products of the bvg locus (14, 36, 48) . Some of these determinants are potential antigens for inclusion in newgeneration acellular, atoxic, nonreactogenic vaccines (23, 24) . One of the most promising components for inclusion in such a vaccine is FHA, which plays a major role in bacterial attachment and subsequent colonization of the epithelial respiratory tract during the early stages of disease (44, 45) . FHA may also facilitate the superinfections that commonly complicate this disease because other bacteria may utilize this bridge-acting adhesin (43) and because of the impairment of macrophage responses due to specific interactions mediated by FHA (20) . An immune response against FHA might prevent infection and disease by inhibiting colonization (33) , inducing opsonization (10) , or stimulating cellular responses against the invading bacterium.
Problems in the production of FHA for acellular vaccines include the fermentation of B. pertussis, a human pathogen (problems in production safety) and a fastidious microorganism with slow growth rates (long fermentation times, poor yields), and the contamination of FHA preparations with other virulence factors (which may contribute to some of the side effects of vaccination). Here we report the efficient direct expression of nonfused (i.e., nonhybrid) FHA in Escherichia coli. Furthermore, we have obtained expression of nonfused FHA in a Salmonella typhimurium aroA strain.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. The bacterial strains used in this work were as follows. The B. pertussis strain used was Tohama serotype 1.2 (34) . E. coli SURE (Stratagene) recB recJ sbcC201 uvrC umuC: :TnS (Kn) mcrA mcrB mrr lac AhsdRMS endAl gyrA96 thi relAl supE44 F' (proAB lacIqZAM15 TnlO) and E. coli JM109 endAl recAl hsdR17 supE44 thi gyrA96 A(lac-proAB) F' (traD36 proAB+ lacIqZAM15) (49) were used for transformations when recombinant clones were screened for ,3-galactosidase alpha complementation, whereas E. coli CC118 araD139 A(ara leu)7697 AlacX74 phoA20 galE galK thi-I rpsE (Spr) rpoB argE(Am) recAl Rif' (17) was used as a recipient strain for other transformations. E. coli 537(pCI857TS) (22) was used for the induction of MS2 polymerase fusions. E. coli 876 pep (R. Brownlie), E. coli EC538 (J. E. G. McCarthy), and E. coli CAG629 Ion htpR165::TnJO (C. Gross) were used as recipient strains in induction experiments for the expression of FHA. E. coli SK5003 F-leu thr Cmr rnb-500 pnp-7 (7) was used in experiments to assess mRNA degradation. E. coli K38X(pGP1-2) Kmr (28, 42) , BL21 DE3, and BL21 DE3(pLysS) (41) were used for the expression of pT7-7 constructions; S. typhimurium SL5283 (B. A. Stocker), a galE503 derivative of LB5000 hsdSB121 leu-3121 (31), was used as an intermediate strain in the transfer of plasmids by transformation from E. coli to S. typhimurium SL3261 aroA (12) . The plasmids used in this work were pUC18NotI (11), pEX31A and pEX31B (40) , pJLA503 (37), pT7-7 (S. Tabor), and pRMB2 (2) . Plasmid pLG612-1 (I. B. Holland) was used as a source of the 23-kDa COOH-terminal signal sequence of hemolysin A, and plasmid pLG575 (16) was used as a source of the hemolysin B accessory genes.
E. coli and S. typhimurium strains were grown in Luria broth or on Luria agar (29) . 5-Bromo-4-chloro-3-indolyl-,-D-galactopyranoside medium (29) was used for selection 3788 GUZMAN ET AL. chloramphenicol (50 ,ug/ml) , and tetracycline (50 p.g/ml). Broth cultures were aerated by shaking at 200 rpm in a New Brunswick environmental incubator shaker.
DNA manipulations. Plasmids were isolated by alkaline lysis (29) . Restriction endonuclease digestion, ligation with T4 DNA ligase, T4 polynucleotide kinase end labeling, dephosphorylation with fetal calf intestinal phosphatase, and transformation were performed as described by Sambrook et al. (29) . Enzymes were obtained from Boehringer Mannheim. DNA sequencing was carried out by the chain termination method of Sanger et al. (32) . Oligonucleotides were synthesized with an Applied Biosystems model 380B DNA synthesizer in accordance with the manufacturer's instructions.
RNA isolation and primer extension analysis. RNA was isolated as previously described (47 40, 300 ,ug. On day 50, the rabbits were sacrificed and the serum was collected, pooled, and stored at -20°C until used. Western blotting (immunoblotting) was carried out essentially as described by Burnette (3) . Prestained molecular weight markers were purchased from Bio-Rad.
Immunoelectron microscopy. Cells were fixed with 0.5% formaldehyde and 0.2% glutaraldehyde (final concentrations) in Luria broth for 1 h on ice. After several washings with 10 mM glycine-50 mM potassium phosphate buffer-0.9% NaCl (pH 6.9), cells were embedded by the method of progressive lowering of temperature (27) with Lowicryl K4M resin, modified as follows: (i) the infiltration with 1 part ethanol and 1 part K4M resin was done overnight, (ii) the infiltration with 1 part ethanol and 2 parts K4M resin was done for 12 h, and (iii) the infiltration with pure resin was done for 2 days with several changes of the resin. Recombinant FHA was detected with polyclonal antibodies against FHA that had been cross-absorbed with E. coli and S. typhimurium aroA and purified by affinity chromatography with protein A-Sepharose CL-4B. Antibodies bound to sample preparations were visualized by incubation with protein A-gold (gold particle size, 10 nm) complexes after preparation of ultrathin sections (postembedding protocol) as previously described (25, 26) . The protein A-gold complexes were produced by established procedures (38) .
Pulse-chase experiments. Cultures were grown to the exponential phase at 30°C (A590 0.7). A 0.7-ml sample was removed, and the cells were harvested by centrifugation, resuspended, and washed with 1.0 ml of minimal M9 medium (29) . After resuspension in 1.0 ml of M9 medium supplemented with 0.02% each amino acid except for methionine and cysteine, the cells were grown for a further 1 h at 30°C. Cultures were induced at 42°C for 10 min, pulsed with 10 ,uCi of "5S-methionine (Amersham) for 5 min at 30°C, chased by centrifugation, and resuspended in supplemented M9 medium containing 0.1% cold methionine. Samples were removed at intervals, centrifuged, washed with ice-cold M9 medium, and prepared for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Radiolabeled molecular weight markers were purchased from Amersham. (11) in both orientations with respect to the lac promoter present in the vector to produce hybrids pCG3 and pCG2 (Fig. 1A) . The hybrid plasmids were transformed into E. coli CAG629, EC538, and 876; very weak expression of FHA was detected only with pCG3 in host strain CAG629, and only then after induction with 1 mM IPTG (Fig. 1C, lane 5) .
RESULTS

Mapping
Expression vector pJLA503 (37) was used to construct a system for the direct expression of FHA. This plasmid contains thermoregulated tandem PR and PL promoters and the highly efficient E. coli atpE translation initiation region (TIR). The original vector multiple cloning site was modified to construct pJLACG1 ( Fig. 2A and B) . This new expression vector contained sites for cloning of the fhaB gene and in-frame stop codons. The start codon of the fhaB ORF for our manipulations was selected on the basis of the information published by Domenighini et al. (6) .
Hybrid plasmids pCG14 and pCG18 (Fig. 1A) were obtained by subcloning the 5.9-kb SphI-BglII and 8.4-kb SphISphI fragments in-frame with the ATG start codon present in the NdeI site and the translational stop codons provided by the linker NdeI-SalI (TAA-TAA). Four extra amino acids are encoded between the NdeI and SphI sites of the vector and the FHA sequence. In hybrid plasmid pCG27, these four superfluous amino acids were removed by the addition of the NdeI-SphI linker (Fig. 2D ) to pCG14 upstream of the SphIBglII fragment; this linker encodes the first 15 amino acids of FHA and was designed to optimize mRNA structure, as predicted by the Zucker-Stiegler program (50), 50 nucleotides upstream and downstream of position +1 (first nucleotide of the start codon), and to reduce RNA secondary structure stability between the NH2-terminal coding region and the atpE TIR ( Fig. 2C and D) . Amino acid sequence fidelity was maintained by the mutagenesis strategy, and E. coli major amino acid codons were preferentially used. Hybrid plasmid pCG26 was constructed by subcloning the 3.7-kb Bglll-EcoRI fragment into pCG27. Hybrid pCG32 was obtained by digestion of pCG27 with SphI and EcoRI, removal of the 5.9-kb SphI-EcoRI fragment, and introduction of the SphI-EcoRI linker (Fig. 2E ). This recombinant plasmid (pJLACG1 plus NdeI-SphI linker plus SphI-EcoRI linker) was digested with SphI, and the 8.4-kb SphI-SphI fragment was introduced.
To determine whether COOH terminus stability affects FHA expression and to attempt to obtain the secretion of FHA, we constructed two further clones in which the C-terminal 23-kDa export signal of the hemolysin A gene (hlyA) was inserted in-frame as an EcoRI-HpaI insert downstream of the FHA determinant of pCG26 and pCG27 to form pCG28 and pCG29, respectively.
A third expression system used was based on plasmid pT7-7, which contains the T7 RNA polymerase promoter 410 and the translational start site for the T7 10 protein. Plasmids isolated from the latter strain were used to transform S. typhimurium SL3261 aroA, although it was not possible to obtain transformants containing pCG28. After induction at 42°C, total cellular extracts were subjected to SDS-PAGE and then to Western blotting to test for the presence of recombinant FHA (Fig. 1B and C) . Expression of FHA was found only in hybrid strains carrying plasmids (pCG18, pCG32, pCG26, and pCG28) containing the larger inserts. We observed important differences in expression relating to the host strain used; these ranged from weak expression in CAG629 to strong expression in 876 and EC538. These data emphasize the importance of host strain selection for the expression of FHA.
Variations in the expression efficiency were also observed with different combinations of hybrid plasmids and host strains: in CAG629, maximal expression was obtained with pCG18, and less was obtained with pCG3, pCG32, and pCG26 (Fig. 1C, lanes 5 to 8) ; in EC538 and 876, maximal expression was obtained with pCG26 and pCG32, and less was obtained pCG18 (Fig. 1C, lanes 10 to 12 and 13 to 15) . Recombinant S. typhimurium strains showed patterns of FHA expression similar to those of EC538 and 876, with pCG18 giving only weak signals and pCG32 and pCG26
giving much stronger signals (Fig. 1C, lanes 16 to 18) .
The presence of the NdeI-SphI linker not only restored the NH2 terminus of FHA but also generally increased its level of expression, as can be seen when FHA yields in bacteria containing pCG18 and pCG32 are compared (Fig. 1C, Hybrid plasmids pCG30 and pCG31 (pT7-7 expression system) were introduced by transformation into E. coli K38X(pGP1-2), BL21 DE3 (a B strain deficient in lon protease and ompT outer membrane protease), and BL21 DE3(pLysS) (a strain expressing low levels of T7 lysozyme that inhibit the basal amount of T7 polymerase, which can result in the expression of potentially toxic products in uninduced cells) (41) . Induction at 42°C for the first strain and with 1 mM IPTG for the other strains produced no detectable FHA expression (Fig. 1A) . The Investigation of expressing and nonexpressing clones. To investigate the reasons for the differential expression of FHA in different constructs based on the pJLACG1 expression system, particularly factors such as transcription rates, mRNA degradation, and protein stability, we transformed hybrid plasmids pCG14, pCG18, pCG32, pCG27, pCG26, pCG29, and pCG28 into E. coli SK5003, which is deficient in polynucleotide phosphorylase and thermolabile for RNase II, the two most important enzymes involved in 3'-to-5' degradation of mRNA. After simultaneous induction and inactivation of RNase II by shifting of bacterial cultures to 42°C for either 30 min or 1 h, the expression of FHA was observed only from plasmids that had previously given positive results with other host strains (e.g., Fig. 1C , lanes 19 and 20) . This result suggests that the instability of mRNA due to 3'-to-5' exonucleases is not the cause of the poor expression of FHA in some clones.
To determine whether major differences in transcription initiation from the lambda PR and PL promoters could explain the differences in FHA expression, we assayed total RNA from CAG629 containing clones pCG27 (negative expression) and pCG26 (positive expression) by primer extension with the FHAa probe. In both clones, transcription was directed efficiently by the PL promoter (Fig. 3) . The start of transcription was 173 nucleotides upstream of start codon ATG, in accordance with the PL start site (37) . There was no evidence of another start site further upstream and corresponding to the position of the lambda PR promoter present in the vector, consistent with the finding that less than 5% of transcripts originated from the PR promotor in pJLA503 (17a). Thus, poor transcription initiation is not the cause of poor expression of FHA encoded by pCG27.
To determine whether the mRNA was degraded from the 3' end and whether transcription extended beyond the area complementary to the FHAa probe, we bound total RNA from CAG629 containing hybrid plasmids pCG27 and pCG29 (negative expression) and pCG26 and pCG28 (positive expression) to (Fig.  3C ). This result indicates that the major portion of the FHA gene is transcribed and that the resulting mRNA is reasonably stable in all clones.
To analyze possible differences in efficiencies of translation and stability of the translation product, we performed pulse-chase experiments with E. coli EC538 containing pCG27 and pCG26. After induction, a 5-min pulse with 35S-methionine, and chases varying from 5 to 60 min with cold methionine, the major 200-to 220-kDa band was clearly seen in EC538(pCG26) and persisted without change for at least 1 h (Fig. 3D, lanes 1 to 4) . In corresponding experiments, this band was not detected in cells containing the vector without the insert (data not shown). Analysis of other FHA bands was not possible because of the presence of background proteins encoded by other mRNA species and the appearance and disappearance of other proteins because of the effects of heat shock. The 200-to 220-kDa band was also produced by EC538(pCG27) but was very weak (Fig.  3D, lanes 5 to 8) , suggesting differences between pCG26 and pCG27 in mRNA translation efficiencies.
DISCUSSION
FHA is an important adhesin involved in the early interactions between B. pertussis and host cells (44, 45) . It is a major candidate antigen for incorporation into a new generation of safer vaccines against whooping cough. Until now, however, its production from B. pertussis has been problematic with regard to slow growth rates, low yields, and contamination with pertussis determinants involved in adverse reactions. The goal of the present effort has been to determine conditions that allow high-level expression of nonfused FHA in E. coli.
The estimated coding region for the 200-to 220-kDa FHA protein secreted from B. pertussis is 6.2 kb, approximately the size of the SphI-BglII fragment. However, the FHA ORF extends over 11 kb. In experiments with E. coli and S. typhimurium containing pJLACG1-derived hybrid plasmids, only those inserts extending beyond the coding region for the secreted 200-to 220-kDa protein yielded good expression of standards (in thousands); 2, purified FHA from B. pertussis Tohama; 3, B. pertussis Tohama; 4 to 8, E. coli CAG629 containing pUC18NotI (4) , pCG3 (5), pCG18 (6) , pCG32 (7) , and pCG26 (8); 9 to 12, E. coli EC538 containing pJLACG1 (9), pCG18 (10), pCG32 (11) , and pCG26 (12); 13 to 15, E. coli 876 containing pCG18 (13), pCG32 (14) , and pCG26 (15); 16 to 18, S. typhimurium SL3261 aroA containing pCG18 (16) , pCG32 (17) , and pCG26 (18) ; 19 and 20, E. coli SK5003 containing pCG26 (19) and pCG27 (20) . The main Coomassie blue-stained FHA bands are indicated by an arrow. In all cases, inductions were performed at 42°C for 1 h. FHA. Several experiments were carried out to study the lack of expression of FHA from constructs not containing the COOH-terminal portion of the FHA ORF. The results obtained indicated that mRNA synthesis and stability were not the cause of the difference and that perhaps mRNA translation was lower in constructs with low expression. Interestingly, probes FHAh and Hlyl, specific for the nonexpressed C-terminal portion of the FHA ORF and for the coding region of the C terminus of hemolysin in FHA-hemolysin fusions, respectively, failed to hybridize either to expressing or to nonexpressing clones (Fig. 3C ). This result reflected the failure to detect HlyA protein with a specific polyclonal antiserum against the COOH terminus of hemolysin (data not shown) and suggested that in E. coli the region downstream of the FHAg probe either was not transcribed or was highly unstable. The requirement of this region for FHA expression in E. coli is therefore surprising. The DNA fragment present in expressing clones between the FHAg and FHAh probes may encode a peptide sequence which is involved in the stability of the major FHA band. In cellular extracts of B. pertussis, proteins that reacted with antibodies raised against fusion proteins with the COOH-terminal part of the FHA ORF were detected (6) . Extracts of B. bronchiseptica and B. parapertussis did not react with such antibodies. These results highlight the need for further investigations to elucidate the function of the COOH-terminal part of FHA in both E. coli and Bordetella spp. It would in any case seem that a number of factors, including mRNA instability, the levels of proteases produced in different E. coli strains, the preferential degradation of recombinant FHA due to the absence of protein signals found in expressing clones, and the inherent instability of the FHA protein, may strongly influence levels of expression of recombinant FHA.
The expression of hybrid plasmids in strains EC538 and 876 yielded higher levels of FHA than those observed in wild-type B. pertussis Tohama. The protein was The hyperexpression of recombinant FHA in E. coli, resulting in its biological separation from other pertussis virulence determinants, provides a solution to the problem of contamination of FHA preparations with other Bordetella virulence products and should advance the development of a recombinant subunit vaccine against whooping cough. The expression of FHA in E. coli also resolves the difficulties associated with fermenting large quantities of a fastidious, slow-growing human pathogen. The large-scale production of purified FHA may lead to the development of kits for serological studies without the need to culture B. pertussis. The expression of FHA in S. typhimurium aroA mutants offers the possibility for the construction of live vaccine carrier strains of Salmonella spp. expressing pertussis antigens and may provide the opportunity to develop oral whooping cough vaccines that stimulate both mucosal and systemic immunity (12, 13) . These results would appear to open new perspectives for the development of both subunit and live vaccines against whooping cough.
